Bank of New York Mellon’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-14,101
| Closed | -$245K | – | 4123 |
|
2024
Q1 | $245K | Sell |
14,101
-1,689
| -11% | -$29.3K | ﹤0.01% | 3861 |
|
2023
Q4 | $202K | Buy |
15,790
+2,376
| +18% | +$30.5K | ﹤0.01% | 3943 |
|
2023
Q3 | $496K | Sell |
13,414
-164
| -1% | -$6.07K | ﹤0.01% | 3542 |
|
2023
Q2 | $547K | Buy |
13,578
+555
| +4% | +$22.3K | ﹤0.01% | 3531 |
|
2023
Q1 | $944K | Buy |
13,023
+243
| +2% | +$17.6K | ﹤0.01% | 3152 |
|
2022
Q4 | $1.05M | Sell |
12,780
-12,906
| -50% | -$1.06M | ﹤0.01% | 3175 |
|
2022
Q3 | $2.43M | Buy |
25,686
+13,890
| +118% | +$1.31M | ﹤0.01% | 2722 |
|
2022
Q2 | $2.3M | Sell |
11,796
-815
| -6% | -$159K | ﹤0.01% | 2754 |
|
2022
Q1 | $2.93M | Buy |
12,611
+239
| +2% | +$55.5K | ﹤0.01% | 2717 |
|
2021
Q4 | $4.88M | Buy |
12,372
+251
| +2% | +$98.9K | ﹤0.01% | 2477 |
|
2021
Q3 | $5.42M | Buy |
12,121
+1,039
| +9% | +$465K | ﹤0.01% | 2442 |
|
2021
Q2 | $4.31M | Sell |
11,082
-762
| -6% | -$296K | ﹤0.01% | 2559 |
|
2021
Q1 | $4.25M | Sell |
11,844
-381
| -3% | -$137K | ﹤0.01% | 2510 |
|
2020
Q4 | $6M | Buy |
12,225
+1,188
| +11% | +$583K | ﹤0.01% | 2275 |
|
2020
Q3 | $3.58M | Buy |
11,037
+1,184
| +12% | +$384K | ﹤0.01% | 2389 |
|
2020
Q2 | $3.59M | Buy |
9,853
+1,145
| +13% | +$417K | ﹤0.01% | 2368 |
|
2020
Q1 | $1.85M | Buy |
8,708
+236
| +3% | +$50.2K | ﹤0.01% | 2584 |
|
2019
Q4 | $3.49M | Sell |
8,472
-336
| -4% | -$138K | ﹤0.01% | 2523 |
|
2019
Q3 | $3.11M | Buy |
8,808
+1,070
| +14% | +$378K | ﹤0.01% | 2516 |
|
2019
Q2 | $3.89M | Buy |
7,738
+357
| +5% | +$180K | ﹤0.01% | 2456 |
|
2019
Q1 | $7.34M | Sell |
7,381
-46
| -0.6% | -$45.7K | ﹤0.01% | 2135 |
|
2018
Q4 | $6.45M | Buy |
7,427
+247
| +3% | +$215K | ﹤0.01% | 2146 |
|
2018
Q3 | $7.42M | Buy |
7,180
+34
| +0.5% | +$35.1K | ﹤0.01% | 2198 |
|
2018
Q2 | $6.57M | Buy |
7,146
+259
| +4% | +$238K | ﹤0.01% | 2242 |
|
2018
Q1 | $6.72M | Buy |
6,887
+1,718
| +33% | +$1.68M | ﹤0.01% | 2192 |
|
2017
Q4 | $2.34M | Buy |
5,169
+216
| +4% | +$97.7K | ﹤0.01% | 2747 |
|
2017
Q3 | $2.05M | Sell |
4,953
-76
| -2% | -$31.4K | ﹤0.01% | 2821 |
|
2017
Q2 | $1.76M | Buy |
5,029
+225
| +5% | +$78.7K | ﹤0.01% | 2922 |
|
2017
Q1 | $2.47M | Buy |
4,804
+243
| +5% | +$125K | ﹤0.01% | 2718 |
|
2016
Q4 | $1.62M | Buy |
4,561
+775
| +20% | +$275K | ﹤0.01% | 2977 |
|
2016
Q3 | $2.02M | Sell |
3,786
-199
| -5% | -$106K | ﹤0.01% | 2754 |
|
2016
Q2 | $2.24M | Buy |
3,985
+688
| +21% | +$387K | ﹤0.01% | 2646 |
|
2016
Q1 | $1.57M | Sell |
3,297
-200
| -6% | -$95.1K | ﹤0.01% | 2804 |
|
2015
Q4 | $2.31M | Sell |
3,497
-29
| -0.8% | -$19.1K | ﹤0.01% | 2628 |
|
2015
Q3 | $2.77M | Buy |
3,526
+484
| +16% | +$381K | ﹤0.01% | 2536 |
|
2015
Q2 | $4.01M | Buy |
3,042
+1,843
| +154% | +$2.43M | ﹤0.01% | 2500 |
|
2015
Q1 | $1.25M | Buy |
1,199
+401
| +50% | +$417K | ﹤0.01% | 3171 |
|
2014
Q4 | $534K | Buy |
+798
| New | +$534K | ﹤0.01% | 3594 |
|